Your browser doesn't support javascript.
loading
Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment.
Poordad, Fred; Felizarta, Franco; Asatryan, Armen; Sulkowski, Mark S; Reindollar, Robert W; Landis, Charles S; Gordon, Stuart C; Flamm, Steven L; Fried, Michael W; Bernstein, David E; Lin, Chih-Wei; Liu, Ran; Lovell, Sandra S; Ng, Teresa I; Kort, Jens; Mensa, Federico J.
Afiliación
  • Poordad F; Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX.
  • Felizarta F; Private Practice, Bakersfield, CA.
  • Asatryan A; AbbVie Inc, North Chicago, IL.
  • Sulkowski MS; Johns Hopkins University School of Medicine, Baltimore, MD.
  • Reindollar RW; Piedmont Healthcare/Carolinas Center for Liver Disease, Statesville, NC.
  • Landis CS; Division of Gastroenterology, University of Washington, Seattle, WA.
  • Gordon SC; Henry Ford Health System, Detroit, MI.
  • Flamm SL; Northwestern Feinberg School of Medicine, Chicago, IL.
  • Fried MW; University of North Carolina, Chapel Hill, NC.
  • Bernstein DE; North Shore University Hospital, Manhasset, NY.
  • Lin CW; AbbVie Inc, North Chicago, IL.
  • Liu R; AbbVie Inc, North Chicago, IL.
  • Lovell SS; AbbVie Inc, North Chicago, IL.
  • Ng TI; AbbVie Inc, North Chicago, IL.
  • Kort J; AbbVie Inc, North Chicago, IL.
  • Mensa FJ; AbbVie Inc, North Chicago, IL.
Hepatology ; 66(2): 389-397, 2017 08.
Article en En | MEDLINE | ID: mdl-28128852

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Quinoxalinas / Ribavirina / Sulfonamidas / Bencimidazoles / Interferón-alfa / Hepatitis C Crónica Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Hepatology Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Quinoxalinas / Ribavirina / Sulfonamidas / Bencimidazoles / Interferón-alfa / Hepatitis C Crónica Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Hepatology Año: 2017 Tipo del documento: Article